Palisade Research Development from 2010 to 2026

PALI Stock  USD 1.73  0.01  0.57%   
Palisade Bio's Research Development is increasing with stable movements from year to year. Research Development is predicted to flatten to about 6.9 M. For the period between 2010 and 2026, Palisade Bio, Research Development quarterly trend regression had mean deviation of  2,476,187 and range of 12.3 M. View All Fundamentals
 
Research Development  
First Reported
2006-06-30
Previous Quarter
1.7 M
Current Value
1.4 M
Quarterly Volatility
812.6 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Palisade Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Palisade Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 K, Interest Expense of 13.1 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 17.64, Dividend Yield of 0.0 or PTB Ratio of 0.29. Palisade financial statements analysis is a perfect complement when working with Palisade Bio Valuation or Volatility modules.
  
Build AI portfolio with Palisade Stock
Check out the analysis of Palisade Bio Correlation against competitors.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.
The Research Development trend for Palisade Bio offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Palisade Bio is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Palisade Bio's Research Development Growth Pattern

Below is the plot of the Research Development of Palisade Bio over the last few years. It is Palisade Bio's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Palisade Bio's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Pretty Stable
   Research Development   
       Timeline  

Palisade Research Development Regression Statistics

Arithmetic Mean6,831,269
Geometric Mean5,687,946
Coefficient Of Variation49.13
Mean Deviation2,476,187
Median6,893,000
Standard Deviation3,356,285
Sample Variance11.3T
Range12.3M
R-Value0.10
Mean Square Error11.9T
R-Squared0.01
Significance0.69
Slope68,724
Total Sum of Squares180.2T

Palisade Research Development History

20266.9 M
202510.4 M
20249.1 M
20236.9 M
20226.5 M
20212.4 M
20203.1 M

About Palisade Bio Financial Statements

Investors use fundamental indicators, such as Palisade Bio's Research Development, to determine how well the company is positioned to perform in the future. Although Palisade Bio's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Research Development10.4 M6.9 M

Currently Active Assets on Macroaxis

When determining whether Palisade Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palisade Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palisade Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palisade Bio Stock:
Check out the analysis of Palisade Bio Correlation against competitors.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is there potential for Biotechnology market expansion? Will Palisade introduce new products? Factors like these will boost the valuation of Palisade Bio. Anticipated expansion of Palisade directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.07)
Return On Assets
(0.88)
Return On Equity
(2.29)
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Palisade Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Palisade Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Palisade Bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.